
"An epidemic of this magnitude requires us to address all aspects of the problem."

"An epidemic of this magnitude requires us to address all aspects of the problem."

The company says the new system is “designed for the post-Meaningful Use era.”

Patients and physicians are more receptive to wearables than ever, but the industry's old guard have continued to see their share of the market slide.

A team of researchers from Harvard and Brigham and Women's says that their new methodology will be made freely available to other researchers.

The practice seems like it’s ripe for data and analytics, and that’s true—to an extent.

The leading artificial intelligence firm will have more room to work with.

The agency continued its march towards tech-savviness by announcing a partnership with AI firm DeepMind.

In a study at Johns Hopkins, the Corrie app produced impressive results. As always, however, accessibility remains a question for digital interventions.

The newly-announced Bella system uses gaze-based VR, which allows patients to ditch the controller and simply look around.

Patients, physicians, regulators, manufacturers, and professional societies must make informed decisions based on new threats.

The move is meant to encourage publically-traded companies—like some healthcare services companies that were recently hit—to be more transparent about breaches and vulnerabilities.

The physician social network now has a wealth of capabilities—and responsibilities—its founders never could've imagined.

The cash injection is the largest investment round to date for rising oncology analytics firm.

Meanwhile, Horizon Blue Cross Blue Shield of New Jersey settled another data breach case for $1 million.

Many of those programs found to have “significant methodological weaknesses and gaps in results."

“Don’t be afraid to learn about the discipline of data governance. The great news is, you’re probably already doing some of this."

The contract with Cerner is again expected to be finalized soon, but the agency head stressed the complexity of the project.

The pharma giant likes the start-up's EHR and real-world evidence technologies and its big network of oncology providers.

The company's founders say they want to make a world where "cancer is managed just like the common cold” and "100 years old is the new 60.”

It will not be dependent on smartphone connection for cellular coverage.

Nearly 9 months after it was announced, the deal has not been finalized. Some lawmakers are expressing frustration.

Today's decision does more than just allow Viz.AI Contact to be marketed: It sets a standard for future software of its kind.

"I think we are much closer to real, practical medical applications of the technology."

Evolution might be important for Fitbit as the market for wearable devices becomes more complicated.

CSC was hired to replace the state's legacy Medicaid processing system. The arrangement quickly turned sour.

It calls for substantial cuts to HHS divisions that oversee patient data privacy and interoperability initiatives.

Andrew Norden, MD, says that he thinks the 2 companies' technologies together are "unsurpassed."

November through February are often marked by an uptick in cyberattacks, security expert Dustin Hutchison explains.

The genomics company said the money will go towards strengthening its intellectual property positions and commercializing 1 of its cancer assays

“Healthcare has always been a very noble profession,” Taha Jangda said. “But it’s also been very transactional.”